Group One Trading
BNTX icon

Group One Trading’s BioNTech BNTX Stock Holding History

Group One Trading’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.88M Sell
21,200
-36,400
-63% -$3.74M ﹤0.01% 2121
2025
Q4 		$5.48M Buy
57,600
+39,200
+213% +$3.95M 0.01% 1409
2025
Q3 		$1.81M Sell
18,400
-39,200
-68% -$4.19M ﹤0.01% 2416
2025
Q2 		$6.13M Sell
57,600
-3,900
-6% -$394K 0.01% 1161
2025
Q1 		$5.6M Sell
61,500
-75,600
-55% -$8.46M 0.02% 987
2024
Q4 		$15.6M Sell
137,100
-122,500
-47% -$14M 0.04% 479
2024
Q3 		$30.8M Buy
259,600
+137,100
+112% +$12.6M 0.09% 173
2024
Q2 		$9.84M Buy
122,500
+71,100
+138% +$6.5M 0.04% 457
2024
Q1 		$4.74M Sell
51,400
-136,700
-73% -$13.1M 0.02% 860
2023
Q4 		$19.9M Buy
188,100
+122,400
+186% +$12.3M 0.05% 351
2023
Q3 		$7.14M Sell
65,700
-21,300
-24% -$2.36M 0.02% 709
2023
Q2 		$9.39M Buy
87,000
+37,300
+75% +$4.2M 0.03% 545
2023
Q1 		$6.19M Sell
49,700
-118,500
-70% -$16.3M 0.02% 728
2022
Q4 		$25.3M Buy
168,200
+44,700
+36% +$6.88M 0.06% 323
2022
Q3 		$16.7M Buy
123,500
+900
+0.7% +$138K 0.03% 475
2022
Q2 		$18.3M Sell
122,600
-15,300
-11% -$2.34M 0.03% 521
2022
Q1 		$23.5M Sell
137,900
-108,500
-44% -$18.2M 0.02% 531
2021
Q4 		$63.5M Buy
246,400
+23,600
+11% +$6.46M 0.05% 249
2021
Q3 		$60.8M Buy
222,800
+116,200
+109% +$36.9M 0.07% 232
2021
Q2 		$23.9M Buy
106,600
+30,300
+40% +$5.71M 0.03% 537
2021
Q1 		$8.33M Sell
76,300
-35,100
-32% -$3.73M 0.01% 1078
2020
Q4 		$9.08M Sell
111,400
-87,100
-44% -$8.55M 0.02% 865
2020
Q3 		$13.7M Buy
198,500
+169,900
+594% +$12.2M 0.04% 397
2020
Q2 		$1.91M Buy
+28,600
New +$1.43M 0.01% 1498

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading's BNTX Position: Q1 2026 in Review

Group One Trading increased its BioNTech (BNTX) stake by 4,185% in Q1 2026, buying an estimated $10.4M and bringing the position to 103,948 shares worth $9.24M. The position accounts for 0.02% of the portfolio, ranked #890.

Group One Trading first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $38.1M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Group One Trading held 103,948 shares of BioNTech worth $9.24M as of Q1 2026.
  • Group One Trading bought 101,522 BioNTech shares in Q1 2026, an estimated $10.4M.
  • BioNTech made up 0.02% of Group One Trading's portfolio in Q1 2026, its #890 holding.
  • Group One Trading first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • Group One Trading's BioNTech position peaked at $38.1M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.